- Alglucerase
-
Alglucerase Systematic (IUPAC) name Human beta-glucocerebrosidase Clinical data AHFS/Drugs.com monograph MedlinePlus a692001 Pregnancy cat. ? Legal status ? Pharmacokinetic data Half-life 3.6–10.4 min Identifiers CAS number 37228-64-1 ATC code A16AB01 DrugBank BTD00037 UNII 27T56C7KK0 KEGG D09675 ChEMBL CHEMBL1201633 Chemical data Formula C2532H3854N672O711S16 Mol. mass 55597.4 g/mol (what is this?) (verify) Alglucerase is a modified form of human β-glucocerebrosidase where the non-reducing ends of the oligosaccharide chains have been terminated with mannose residues. Ceredase is the trade name of a citrate buffered solution of alglucerase manufactured by Genzyme Corporation from human placental tissue. It is given intravenously in the treatment of Type 1 Gaucher's disease although it has been largely replaced by imiglucerase which is produced by recombinant DNA technology.[citation needed]
External links
Other alimentary tract and metabolism products (A16) Amino acids and derivatives Enzymes Carbohydrate metabolism: sucrase (Sacrosidase) • alpha-glucosidase (Alglucosidase alfa)
Glycolipid/sphingolipid: glucocerebrosidase (Alglucerase, Imiglucerase, Velaglucerase alfa) • alpha-galactosidase (Agalsidase alfa, Agalsidase beta)
Glycosaminoglycan: iduronidase (Laronidase) • arylsulfatase B (Galsulfase) • iduronate-2-sulfatase (Idursulfase)Various alimentary tract
and metabolism productsTioctic acid • Anethole trithione • Sodium phenylbutyrate • Nitisinone • Zinc acetate • Miglustat • SapropterinThis drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.